Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency

ASAIO Journal

Volumn 43, Issue 4, 1997, Pages 365-369

  Adamson, R M ^a,c   Dembitsky, W P ^a   Jaski, B E ^a   Daily, P O ^a   Moreno, R ^a   Kim, J C ^a   Sono, J ^b   Akasaka, T ^b   Hoagland, P M ^a   Gordon, J B ^a  

^a SHARP MEMORIAL HOSPITAL   (United States)

^b KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSEL PROSTHESES; CARDIOVASCULAR SURGERY; HEMODYNAMICS; IMPLANTS (SURGICAL); PATIENT MONITORING; TRANSPLANTATION (SURGICAL);

LEFT VENTRICULAR ASSIST DEVICE (LVAD);

ARTIFICIAL ORGANS;

ADULT; AORTA VALVE REGURGITATION; ARTICLE; ASSISTED CIRCULATION; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; HEMODYNAMICS; HUMAN; MALE; PULMONARY HYPERTENSION;

ADULT; ALPROSTADIL; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; BIOPROSTHESIS; BLOOD PRESSURE; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; DOBUTAMINE; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART VALVE PROSTHESIS; HEART-ASSIST DEVICES; HUMANS; HYPERTENSION, PULMONARY; INFUSIONS, INTRA-ARTERIAL; MALE; MILRINONE; POSTOPERATIVE COMPLICATIONS; PULMONARY ARTERY; PYRIDONES; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 0343376109     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199707000-00019     Document Type: Article

References (21)

1. Griepp RB, Stinson EB, Dong ED, et al: Determinants of operative risk in human heart transplantation. Am J Surg 122: 192-196, 1971.
2. Addonizio LJ, Gersony WM, Robbins RC, et al: Elevated pulmonary vascular resistance and cardiac transplantation. Circulation 76(suppl V): 52-55, 1987.
3. Costard-Jäkle A, Hill I, Schroeder JS, Fowler MB: The influence of preoperative patient characteristics on early and late survival following cardiac transplantation. Circulation 84(suppl III): 329-337, 1991.
4. Erickson KW, Costanzo-Nordin MR, O'Sullivan J, et al: Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Transplant 9: 526-537, 1990.
5. Kirklin JK, Naftel DC, Kirklin JW, et al: Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant 7: 331-336, 1988.
6. O'Connell JB, Bourge RC, Costanzo-Nordin MR, et al: Cardiac transplantation: recipient selection, donor procurement, and medical follow-up: a statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 86: 1061-1079, 1992.
7. Cooper DKC, Lanza RP: Heart Transplantation (Chapter 20), in Advantages and Disadvantages of Heterotopic Transplantation. 1984, pp. 305-319.
8. Bhatia SJS, Kirshenbaum JM, Shemin RJ, et al: Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation. Circulation 76: 819-826, 1987.
9. Villanueva FS, Murali S, Uretsky BF, et al: Resolution of severe pulmonary hypertension after heterotopic cardiac transplantation. JACC 14: 1239-1243, 1989.
10. Kawaguchi A, Gandjbakhch I, Pavie A, et al. Cardiac transplant recipients with preoperative pulmonary hypertension: evolution of pulmonary hemodynamics and surgical options. Circulation 80(suppl III): 90-96, 1989.
11. Shumway SJ, Baughman KL, Traill TA, et al: Persistent pulmonary hypertension after heterotopic heart transplantation: a case report. J Heart Transplant 8: 387-390, 1989.
12. Murali S, Uretsky BF, Reddy PS, Tokarczyk TR, Betschart AR: Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents. Am Heart J 122: 1375-1381, 1991.
13. Zales VR, Pahl E, Backer CL, et al: Pharmacologic reduction of pretransplantation pulmonary vascular resistance predicts outcome after pediatric heart transplantation. J Heart Lung Transplant 12(part 1): 965-972, 1993.
14. Bolling SF, Deeb GM, Crowley DC, Badellino MM, Bove EL: Prolonged amrinone therapy prior to orthotopic cardiac transplantation in patients with pulmonary hypertension. Transplant Proc 20(suppl 1): 753-756, 1988.
15. Murali S, Kormos RL, Uretsky BF, et al: Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J 126: 896-904, 1993.
16. Costard-Jäckle A, Fowler MB: Influence of preoperative pulmonary pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 19: 48-54, 1992.
17. 1 in the evaluation of heart failure patients with significant pulmonary hypertension. J Heart Lung Transplant 11: 716-723, 1992.
18. Bourge RC, Naftel DC, Costanzo-Nordin MR, et al. Pretransplantation risk factors for death after heart transplantation: a multi-institutional study. J Heart Lung Transplant 12: 549-562, 1993.
19. Kirklin JK, Naftel DC, McGriffin DC, et al: Analysis of morbid events and risk factors for death after cardiac transplantation. J Am Coll Cardiol 11: 917-924, 1988.
20. Heath D, Edwards JE: The pathology of hypertensive pulmonary vascular disease. Circulation 18: 533, 1958.
21. Jaski BE, Branch KR, Adamson RM, et al: Exercise hemodynamics during long-term implantation of a left ventricular assist device in patients awaiting heart transplantation. J Am Coll Cardiol 22: 1574-1580, 1993.